BOSTON — Improvements in frailty among patients with cirrhosis awaiting liver transplantation lowered the risk for mortality regardless of baseline frailty and MELD-Na score, according to data presented at The Liver Meeting 2019.“Of the many studies out there on frailty in patients with cirrhosis, they’ve been limited by the fact that frailty has been measured at a single time point and, while that’s entirely valid, we as clinicians know that frailty is rather dynamic,” Jennifer Cindy Lai, MD, University of California, San Francisco, said during her presentation. “So,Read More